Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

93 results
Display

In vitro susceptibilities of bacteroides fragilis group organisms: comparison of the strains isolated in 1990 with 1991

Lee KW, Jung YS, Kwon OH, Chang IH, Yoon KJ, Kim SJ

  • KMID: 1699692
  • Korean J Infect Dis.
  • 1993 Feb;25(1):27-32.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Patient-Specific Tumor Microenvironment Models

Lee JW, Kim J, Shin Y, Chi BH, Kim JH, Chang IH, Choi SY

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Development of Antibody-Drug Conjugates for Urothelial Carcinoma Treatment

Choi DS, Kang SJ, Chang IH, Choi YW

Urothelial cancer is the seventh most common cancer among men worldwide. Bacille de Calmette-Guérin is a type of anticancer immunotherapy that has been used to treat targeted bladder cancer, but...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Vascularization Methods for Tissue Engineers

Kim MJ, Chi BH, Cho MJ, Whang YM, Chang IH

Tissue engineering is limited by our inability to adequately vascularize tissues post implantation because all tissue-engineered substitutes (with the exception of cornea and cartilage) require a vascular network to provide...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Present and Future of Intravesical Therapy in Bladder Cancer

Seong SW, Shin Y, Chang IH, Kim JH

Intravesical therapy is the gold standard in the treatment of nonmuscle invasive bladder cancer (NMIBC). Despite the efficacy of intravesical therapies, the best treatment options are not determined yet. Development...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Manipulating the Angiogenesis by Inflammation

Kim MJ, Jin S, Whang YM, Chang IH

There exists a need to develop strategies that promote neovascularization in virtually all tissue engineering and regenerative medicine efforts. While research typically focuses on understanding and exploiting the role of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Erratum: Correction of Acknowledgement. Establishment of an Orthotopic Mouse Non-Muscle Invasive Bladder Cancer Model Expressing the Mammalian Target of Rapamycin Signaling Pathway

Kim SJ, Seo HK, Seo HH, Lee SJ, Kwon JK, Lee TJ, Chi BH, Chang IH

We found an error in our published article.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recombinant Bacille Calmette–Guérin for Immunotherapy in Nonmuscle Invasive Bladder Cancer

Jin S, Whang YM, Chang IH

Intravesical instillation of Mycobacterium bovis bacille Calmette–Guérin (BCG) has been used for treating nonmuscle invasive bladder cancer as the forefront of immunotherapy, but BCG is ineffective in approximately 30–40% of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Implications of Urinary Microbiome in Bladder Cancer

Shim JH, Gook JH, Chang IH, Sohn JM, Seong SW, Chi BH

Microbiomes are known to have a beneficial effect on human health by promoting the effective removal of improperly functioning immune cells and protecting the host from pathogen infection. On the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Laparoscopic Repair of Large Bladder Herniation Presenting as an Inguinal Hernia

Lee JY, Oh SY, Chang IH, Choe JW, Park SH, Ryu JH, Lee DM, Ryu YW, Lim SW

  • KMID: 2316079
  • Korean J Urol.
  • 2013 Feb;54(2):139-142.
The bladder is involved in 1% to 3% of all hernia cases. We report a case of a large paraperitoneal bladder hernia (BH) in a 59-year-old man who had a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A novel strategy for treatment of bladder cancer: Antibody-drug conjugates

Kim JH, Chang IH

In the past, there was no second-line chemotherapeutic agent suitable for use when urothelial carcinoma (UC) progressed to platinum-resistant UC. However, recently, several new treatment options, such as immune checkpoint...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Overdiagnosis of Kidney Cancer in Koreans and the Active Surveillance on Small Renal Mass

Chi BH, Chang IH

While overtreatment in medical services had been the topic of interest among the medical community for a long time, there are numerous academic papers concerning over-diagnosis nowadays. The use of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Nanomedicines for Therapy of Bladder Cancer

Song C, Jang SJ, Jeon WH, Maeng S, Tae JH, Chang IH

Bladder cancer is one of most common malignant urinary tract tumor types, and transurethral resection of nonmuscle invasive bladder cancer followed by intravesical instillation of immunochemotherapy is the standard treatment...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Application of Bioprinting to Cancer Research

Cho MJ, Chi BH, Kim MJ, Whang YM, Chang IH

Three-dimensional (3D) printing is an additive manufacturing process by which precursor materials are deposited layer by layer to form complex 3D geometries from computer-aided designs, and bioprinting offers the ability...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Animal models of bone metastatic prostate cancer

Tae JH, Chang IH

Metastatic disease is a main cause of mortality in prostate cancer and remains to be incurable despite emerging new treatment agents. Development of novel treatment agents are confined within the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Predicting Recurrence and Progession of Non Muscle Invasive Urothelial Cell Carcinoma of Bladder by Clinical and Pathological Prognostic Factors

Choi SY, Chang IH

About 80% of Bladder cancer is non muscle invasive bladder cancer (NMIBC). Despite of appropriate therapy, a lot of NMIBC recur as a superficial tumor or progress to muscle invasive...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Delayed Presentation of Intravesical Bone Penetration after Pelvic Ring Fracture

Kim JH, Ha YC, Kim TH, Myung SC, Moon YT, Kim KD, Chang IH

Retrograde cystography and computed tomography (CT) are considered the gold standard for investigating bladder and pelvic bone injury. However, these methods can miss extraperitoneal bladder rupture caused by a penetrating...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer

Jeong J, Ha JB, Chang IH

For intermediate- and high-risk nonmuscle invasive bladder cancer (NMIBC), intravesical Bacillus Calmette-Guérin (BCG) therapy is the standard adjuvant treatment following transurethral resection of bladder tumor. Although intravesical BCG therapy improves...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current Trends in Liquid Biopsy Technology for Early Diagnosis of Metastatic Renal Cell Carcinoma

Suh JY, Maeng SJ, Kim M, Kang SJ, Choi YW, Chang IH

Clear cell renal cell carcinoma (ccRCC) is a disease with a wide variety of clinical progressions such as the rate of disease progression or the degree of metastasis. About 30%...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Animal Models for Bone Metastatic Prostate Cancer

Jeon WH, Song C, Jang SJ, Maeng S, Chang IH, Tae JH

Metastatic disease is a main cause of mortality in prostate cancer and remains to be uncurable despite emerging new treatment agents. Development of novel treatment agents are confined within the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr